STOK logo

Stoke Therapeutics, Inc. (STOK) CAPEX

Annual CAPEX:

$203.00K-$1.41M(-87.44%)
December 31, 2024

Summary

  • As of today, STOK annual capital expenditures is $203.00 thousand, with the most recent change of -$1.41 million (-87.44%) on December 31, 2024.
  • During the last 3 years, STOK annual CAPEX has fallen by -$997.00 thousand (-83.08%).
  • STOK annual CAPEX is now -94.88% below its all-time high of $3.96 million, reached on December 31, 2022.

Performance

STOK CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

Quarterly CAPEX:

$132.00K-$22.00K(-14.29%)
September 30, 2025

Summary

  • As of today, STOK quarterly capital expenditures is $132.00 thousand, with the most recent change of -$22.00 thousand (-14.29%) on September 30, 2025.
  • Over the past year, STOK quarterly CAPEX has increased by +$29.00 thousand (+28.16%).
  • STOK quarterly CAPEX is now -93.50% below its all-time high of $2.03 million, reached on September 30, 2022.

Performance

STOK Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

TTM CAPEX:

$480.00K+$29.00K(+6.43%)
September 30, 2025

Summary

  • As of today, STOK TTM capital expenditures is $480.00 thousand, with the most recent change of +$29.00 thousand (+6.43%) on September 30, 2025.
  • Over the past year, STOK TTM CAPEX has increased by +$90.00 thousand (+23.08%).
  • STOK TTM CAPEX is now -87.88% below its all-time high of $3.96 million, reached on December 31, 2022.

Performance

STOK TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKcash flow metrics

STOK CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-87.4%+28.2%+23.1%
3Y3 Years-83.1%-93.5%-87.2%
5Y5 Years-87.6%-50.9%-68.6%

STOK CAPEX Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-94.9%at low-93.5%+1000.0%-87.9%+136.4%
5Y5-Year-94.9%at low-93.5%+1000.0%-87.9%+136.4%
All-TimeAll-Time-94.9%+79.7%-93.5%+1000.0%-87.9%+1746.2%

STOK CAPEX History

DateAnnualQuarterlyTTM
Sep 2025
-
$132.00K(-14.3%)
$480.00K(+6.4%)
Jun 2025
-
$154.00K(+1.3%)
$451.00K(+31.5%)
Mar 2025
-
$152.00K(+261.9%)
$343.00K(+69.0%)
Dec 2024
$203.00K(-87.4%)
$42.00K(-59.2%)
$203.00K(-47.9%)
Sep 2024
-
$103.00K(+123.9%)
$390.00K(-41.8%)
Jun 2024
-
$46.00K(+283.3%)
$670.00K(-54.2%)
Mar 2024
-
$12.00K(-94.8%)
$1.46M(-9.5%)
Dec 2023
$1.62M(-59.2%)
$229.00K(-40.2%)
$1.62M(-10.0%)
Sep 2023
-
$383.00K(-54.4%)
$1.80M(-47.8%)
Jun 2023
-
$839.00K(+408.5%)
$3.44M(+4.8%)
Mar 2023
-
$165.00K(-59.7%)
$3.29M(-17.1%)
Dec 2022
$3.96M(+230.2%)
$409.00K(-79.9%)
$3.96M(+5.5%)
Sep 2022
-
$2.03M(+197.7%)
$3.76M(+87.9%)
Jun 2022
-
$682.00K(-18.9%)
$2.00M(+8.8%)
Mar 2022
-
$841.00K(+314.3%)
$1.84M(+53.1%)
DateAnnualQuarterlyTTM
Dec 2021
$1.20M(+14.3%)
$203.00K(-25.6%)
$1.20M(+10.4%)
Sep 2021
-
$273.00K(-47.5%)
$1.09M(+0.4%)
Jun 2021
-
$520.00K(+154.9%)
$1.08M(+68.2%)
Mar 2021
-
$204.00K(+126.7%)
$644.00K(-38.7%)
Dec 2020
$1.05M(-35.8%)
$90.00K(-66.5%)
$1.05M(-31.3%)
Sep 2020
-
$269.00K(+232.1%)
$1.53M(-17.0%)
Jun 2020
-
$81.00K(-86.7%)
$1.84M(-14.4%)
Mar 2020
-
$610.00K(+7.4%)
$2.15M(+31.7%)
Dec 2019
$1.64M(+74.9%)
$568.00K(-2.6%)
$1.64M(+53.2%)
Sep 2019
-
$583.00K(+48.7%)
$1.07M(+120.5%)
Jun 2019
-
$392.00K(+326.1%)
$484.00K(+426.1%)
Mar 2019
-
$92.00K(+253.8%)
$92.00K(+253.8%)
Dec 2018
$935.00K(+727.4%)
-
-
Mar 2018
-
$26.00K
$26.00K
Dec 2017
$113.00K
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual capital expenditures?
  • What is the all-time high annual CAPEX for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual CAPEX year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly capital expenditures?
  • What is the all-time high quarterly CAPEX for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM capital expenditures?
  • What is the all-time high TTM CAPEX for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM CAPEX year-on-year change?

What is Stoke Therapeutics, Inc. annual capital expenditures?

The current annual CAPEX of STOK is $203.00K

What is the all-time high annual CAPEX for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual capital expenditures is $3.96M

What is Stoke Therapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, STOK annual capital expenditures has changed by -$1.41M (-87.44%)

What is Stoke Therapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of STOK is $132.00K

What is the all-time high quarterly CAPEX for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly capital expenditures is $2.03M

What is Stoke Therapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, STOK quarterly capital expenditures has changed by +$29.00K (+28.16%)

What is Stoke Therapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of STOK is $480.00K

What is the all-time high TTM CAPEX for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM capital expenditures is $3.96M

What is Stoke Therapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, STOK TTM capital expenditures has changed by +$90.00K (+23.08%)
On this page